1. Communicate potential paradigmatic changes in management and assessment of multiple myeloma

2. Identify novel pathophysiologic mechanism in catastrophic antiphospholipid syndrome

3. Discuss cost-effectiveness considerations with novel oncolytics, using Hodgkin lymphoma as a model

4. Identify and discuss stand-out abstracts from the American Society of Hematology annual meeting 2019

5. Describe rapidly evolving developments in myeloid diseases, including therapeutics and practice recommendations

6. Describe recent advances in immunotherapy for the treatment of mantle cell lymphoma and acute lymphoblastic leukemia

7. Evaluate monitoring of coagulation testing in patients on heparin and implications on clinical management

Session date: 
01/08/2020 - 8:00am to 9:00am CST
Room G5/119 CSC
600 Highland Avenue
Madison, WI 53792
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Ryan Mattison
Matthew Brunner
Muhammad (Umair) Mushtaq